MetLife Investment Management’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281K Buy
63,587
+10,954
+21% +$64.8K ﹤0.01% 2043
2025
Q4
$282K Buy
52,633
+6,916
+15% +$55K ﹤0.01% 2102
2025
Q3
$440K Buy
45,717
+10,820
+31% +$99.8K ﹤0.01% 1866
2025
Q2
$257K Buy
34,897
+3,165
+10% +$21.2K ﹤0.01% 2050
2025
Q1
$149K Buy
31,732
+5,744
+22% +$28.7K ﹤0.01% 2352
2024
Q4
$118K Sell
25,988
-5,834
-18% -$31.1K ﹤0.01% 2548
2024
Q3
$88.5K Buy
+31,822
New +$84.6K ﹤0.01% 2671

Other funds holding ASPI

MetLife Investment Management's ASPI Position: Q1 2026 in Review

MetLife Investment Management increased its ASP Isotopes (ASPI) stake by 21% in Q1 2026, buying an estimated $64.8K and bringing the position to 63,587 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

MetLife Investment Management first reported a position in ASPI in Q3 2024 and has held it in 7 quarters since. The position peaked at $440K in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • MetLife Investment Management held 63,587 shares of ASP Isotopes worth $281K as of Q1 2026.
  • MetLife Investment Management bought 10,954 ASP Isotopes shares in Q1 2026, an estimated $64.8K.
  • ASP Isotopes made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2043 holding.
  • MetLife Investment Management first reported a position in ASP Isotopes in Q3 2024 and has held it in 7 quarters since.
  • MetLife Investment Management's ASP Isotopes position peaked at $440K in Q3 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.